NovoCure’s (NVCR) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of NovoCure (NASDAQ:NVCR – Free Report) in a research report released on Thursday,Benzinga reports. They currently have a $30.00 price objective on the medical equipment provider’s stock. Several other research firms have also recently weighed in on NVCR. Wedbush reaffirmed an “outperform” rating and issued a $24.00 […]
More Stories
The Map of Longing: Release Date, Cast Members, Trailer, and Synopsis
Are you ready for an emotional and loving journey between two sisters? If you are a fan of a chaotic...
Netflix has announced the Release Date for Steps, a Cinderella Spin-Off
Mark your calendar! Netflix has brought an all-new anime film, Steps, for a 2026 release. The film flips the classic...
Avatar: The Last Airbender Season 3: Release Date, Trailer, and Cast Members
Everyone’s favourite animated series, Avatar: The Last Airbender, is coming back with more action-packed visuals to captivate its audience once...
Cyberpunk: Edgerunners Season 2: Release Date, Cast, Trailer, and More
Night City is coming again with its renewal after four years of waiting. Since its first release in 2022, the...
Sakamoto Days Season 2: Release Date, Trailer, and Where to Watch?
Sakamoto Days, the 2025 series, is coming back! For Sakamoto Days fans, the blend of action, comedy, and adventure is...
Is Blue Eye Samurai Season 2 Announced? Release Date, Trailer, and More
Netflix’s adult anime series, Blue Eye Samurai, first premiered in 2023 and has quickly become one of the most acclaimed...